Copyright © 2020 of TiME agency
FB Dermatology is exploring the use of FLE with a view to developing more
non-invasive treatments for a number of skin conditions.
First Fluorescent Light Energy biomodulation patent issued.
Highly efficacious clinical results using FLE for moderate to severe acne vulgaris
Received CE mark approval in Europe for Kleresca® and the use of FLE in Dermatology and Aesthetic Medicine
Received CE mark approval in Europe for LumiHeal™ and the use of FLE for the treatment of chronic and acute wounds.
Initial launch of Kleresca® in Europe and Australia.
Initial launch of LumiHeal™ in Italy
Today, our company is present all over Europe as well as Israel, Australia and New Zealand.
We are committed to expand the use of FLE all over the word as well as to launch new cutting-edge complementary products.
Fill in the form below
© Copyright 2020 FB DERMATOLOGY s.r.l. - VAT: IT02404630440 - All rights reservedVia San Giovanni Scafa - San Benedetto del Tronto - 63074 (AP) - Italia - Web Design: TiME Agency